These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 23416979)

  • 1. Senescence and aging: the critical roles of p53.
    Rufini A; Tucci P; Celardo I; Melino G
    Oncogene; 2013 Oct; 32(43):5129-43. PubMed ID: 23416979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of p53 in the Regulation of Cellular Senescence.
    Mijit M; Caracciolo V; Melillo A; Amicarelli F; Giordano A
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32182711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockin mice expressing a chimeric p53 protein reveal mechanistic differences in how p53 triggers apoptosis and senescence.
    Johnson TM; Meade K; Pathak N; Marques MR; Attardi LD
    Proc Natl Acad Sci U S A; 2008 Jan; 105(4):1215-20. PubMed ID: 18216268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel ARF/p53-independent senescence pathways in cancer repression.
    Chan CH; Gao Y; Moten A; Lin HK
    J Mol Med (Berl); 2011 Sep; 89(9):857-67. PubMed ID: 21594579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two faces of p53: aging and tumor suppression.
    Rodier F; Campisi J; Bhaumik D
    Nucleic Acids Res; 2007; 35(22):7475-84. PubMed ID: 17942417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent discoveries in the cycling, growing and aging of the p53 field.
    McCubrey JA; Demidenko ZN
    Aging (Albany NY); 2012 Dec; 4(12):887-93. PubMed ID: 23425920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stressing the cell cycle in senescence and aging.
    Chandler H; Peters G
    Curr Opin Cell Biol; 2013 Dec; 25(6):765-71. PubMed ID: 23916530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin.
    Zhang Y; Dong Y; Melkus MW; Yin S; Tang SN; Jiang P; Pramanik K; Wu W; Kim S; Ye M; Hu H; Lu J; Jiang C
    Mol Cancer Ther; 2018 Nov; 17(11):2341-2352. PubMed ID: 30166403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms.
    Beck J; Turnquist C; Horikawa I; Harris C
    Carcinogenesis; 2020 Aug; 41(8):1017-1029. PubMed ID: 32619002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence regulation by the p53 protein family.
    Qian Y; Chen X
    Methods Mol Biol; 2013; 965():37-61. PubMed ID: 23296650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging.
    Gambino V; De Michele G; Venezia O; Migliaccio P; Dall'Olio V; Bernard L; Minardi SP; Della Fazia MA; Bartoli D; Servillo G; Alcalay M; Luzi L; Giorgio M; Scrable H; Pelicci PG; Migliaccio E
    Aging Cell; 2013 Jun; 12(3):435-45. PubMed ID: 23448364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
    Ong ALC; Ramasamy TS
    Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing p53 and mTOR/AKT promote an in vivo switch from apoptosis to senescence upon telomere shortening in zebrafish.
    El Maï M; Marzullo M; de Castro IP; Ferreira MG
    Elife; 2020 May; 9():. PubMed ID: 32427102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions.
    Fujita K
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular bridging of aging and cancer: A CARF link.
    Cheung CT; Kaul SC; Wadhwa R
    Ann N Y Acad Sci; 2010 Jun; 1197():129-33. PubMed ID: 20536841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK2 transcriptional repression is an essential effector in p53-dependent cellular senescence-implications for therapeutic intervention.
    Zalzali H; Nasr B; Harajly M; Basma H; Ghamloush F; Ghayad S; Ghanem N; Evan GI; Saab R
    Mol Cancer Res; 2015 Jan; 13(1):29-40. PubMed ID: 25149358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53.
    Lieschke E; Wang Z; Kelly GL; Strasser A
    J Mol Cell Biol; 2019 Mar; 11(3):212-223. PubMed ID: 30496435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in p53 research and cancer treatment.
    Suzuki K; Matsubara H
    J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.
    Kenzelmann Broz D; Attardi LD
    Carcinogenesis; 2010 Aug; 31(8):1311-8. PubMed ID: 20097732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple facets of p53 in senescence induction and maintenance.
    Johmura Y; Nakanishi M
    Cancer Sci; 2016 Nov; 107(11):1550-1555. PubMed ID: 27560979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.